BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,709,000 | -10.5% | 10,000,000 | -9.1% | 0.63% | +21.3% |
| Q2 2023 | $10,848,475 | -9.7% | 11,000,000 | -6.0% | 0.52% | +40.7% |
| Q1 2023 | $12,018,591 | +25.6% | 11,700,000 | +30.0% | 0.37% | +23.7% |
| Q4 2022 | $9,569,790 | +17.2% | 9,000,000 | +9.8% | 0.30% | +9.5% |
| Q3 2022 | $8,163,000 | +0.2% | 8,200,000 | 0.0% | 0.27% | +7.5% |
| Q2 2022 | $8,143,000 | +7.8% | 8,200,000 | +9.3% | 0.26% | +21.4% |
| Q1 2022 | $7,552,000 | – | 7,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 23,984,000 | $24,566,321 | 1.87% |
| SSI INVESTMENT MANAGEMENT LLC | 14,019,000 | $14,383,199 | 1.01% |
| PFM Health Sciences, LP | 15,000,000 | $15,427,185 | 0.68% |
| Sonora Investment Management Group, LLC | 6,380,000 | $6,460,377 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,638,000 | $25,339,666 | 0.48% |
| Lombard Odier Asset Management (Europe) Ltd | 9,000,000 | $9,099,180 | 0.45% |
| RWC Asset Management LLP | 11,700,000 | $12,018,591 | 0.37% |
| MACKAY SHIELDS LLC | 10,450,000 | $10,721,491 | 0.29% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,093,000 | $10,326,148 | 0.28% |
| Nicholas Investment Partners, LP | 2,940,000 | $3,016,378 | 0.23% |